Antiangiogenic efficacy of intravitreal aflibercept versus ranibizumab in a fixed and a PRN-guided regimen in the VIEW2 trial

被引：0

作者：

Waldstein, Sebastian M. ^{[1
]}

Simader, Christian ^{[1
]}

Staurenghi, Giovanni ^{[2
]}

Larsen, Michael ^{[3
,4
]}

Mitchell, Paul ^{[5
]}

Schmidt-Erfurth, Ursula ^{[1
]}

机构：

[1] Med Univ Vienna, Christian Doppler Lab Ophthalm Image Anal, Vienna Reading Ctr, Dept Ophthalmol, Vienna, Austria

[2] Univ Milan, Sch Ophthalmol 2, Eye Clin, Dept Clin Sci,Luigi Sacco Sacco Hosp, Milan, Italy

[3] Univ Copenhagen, Dept Ophthalmol, Glostrup Hosp, Copenhagen, Denmark

[4] Univ Copenhagen, Natl Eye Clin, Copenhagen, Denmark

[5] Univ Sydney, Dept Ophthalmol, Sydney, NSW, Australia

来源：

关键词：

412 age-related macular degeneration; 550 imaging/image analysis: clinical; 453 choroid: neovascularization;

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

3959

引用

页数：3